Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 604 across all filing types
Latest filing 2023-06-01 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares with dates and quantities, and references to rules from the Stock Exchange of Hong Kong (SEHK) Main Board and GEM Listing Rules. The content focuses on reporting share repurchases and changes in issued shares, which aligns with announcements regarding share repurchase activities. There is no indication of financial statements, earnings data, or management discussion. The document is not a report publication announcement but a detailed disclosure of share repurchase transactions. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS).
2023-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return on movements in securities for Kindstar Globalgene Technology, Inc., including authorized share capital, issued shares, share options, repurchases, and confirmations related to securities issued. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content focuses on share capital changes, share options, repurchases, and confirmations of compliance with listing requirements. There is no financial performance data, earnings information, or management discussion. The document is a regulatory submission reporting share capital movements and confirmations, typical of a regulatory filing rather than a financial report or announcement of a report. The length (9162 characters) and detailed tabular data support it being a substantive regulatory filing rather than a brief announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2023-06-01 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It contains detailed data on repurchases of shares, dates, and quantities, as well as confirmations related to share issues and repurchases. The document references compliance with listing rules of the Stock Exchange of Hong Kong and provides detailed transactional data on share repurchases but does not contain financial statements or earnings data. This type of document is a report on the company's transactions in its own shares (share buybacks), which fits the category 'Transaction in Own Shares' (POS). The document length is substantial and contains detailed transactional data, not just an announcement or a brief notice, so it is not a Regulatory Filing or Report Publication Announcement. Therefore, the correct classification is POS with high confidence.
2023-05-31 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It details numerous repurchases of shares with dates and quantities, confirming compliance with listing rules of the Stock Exchange of Hong Kong. The content is focused on reporting share repurchase activity and changes in issued shares, which aligns with announcements of share buybacks or capital changes. There is no indication of full financial statements or detailed financial analysis, so it is not an Annual Report or Interim Report. It is not a regulatory certification or legal proceeding. The document is substantive and detailed, not a brief announcement of a report. Therefore, the best fitting category is 'Transaction in Own Shares' (POS), which covers reports of company buying back or selling its own shares.
2023-05-30 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchases of shares with dates and quantities, referencing compliance with the Main Board Listing Rules and GEM Listing Rules of the Stock Exchange of Hong Kong. The content focuses on reporting share repurchase activities and changes in issued shares, which aligns with announcements of transactions in own shares. There is no indication of it being a full financial report, earnings release, or management discussion. The document is lengthy and detailed, not a brief announcement or certification. Therefore, the document fits best under the category of 'Transaction in Own Shares' (POS).
2023-05-29 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares with dates and quantities, confirming it is a report on transactions involving the company's own shares. The document references compliance with listing rules of the Stock Exchange of Hong Kong and provides confirmations related to share issues and repurchases. There is no indication of financial statements, earnings data, or management discussion. The content is focused on share repurchase activity, which aligns with the category for reports on company buying back or selling its own shares. Therefore, the document fits best under the category 'Transaction in Own Shares' (POS). The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement or certification.
2023-05-25 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.